Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2002 Nov 2;325(7371):980-1.
doi: 10.1136/bmj.325.7371.980.

Treating acute gouty arthritis with selective COX 2 inhibitors

Adel G Fam
Editorial

Treating acute gouty arthritis with selective COX 2 inhibitors

Adel G Fam. BMJ. .
No abstract available

PubMed Disclaimer

References

    1. Fam AG. Strategies and controversies in the treatment of gout and hyperuricemia. In: Ed Bellamy N, editor. Bailliere's clinical rheumatology: controversies in the management of rheumatic diseases. London: Bailliere Tindall; 1990. p. 4. (2):177-92. - PubMed
    1. Terkeltaub R. Pathogenesis of inflammatory manifestations caused by crystals. In: Smyth CJ, Holers VM, editors. Gout, hyperuricemia, and other crystal-associated arthropathies. New York: Marcel Dekker; 1999. pp. 1–14.
    1. Feldman M, McMahon AT. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med. 2000;132:134–143. - PubMed
    1. Jackson CG. Therapeutic potential of COX-2 inhibitors in arthritis. Expert Opin Investig Drugs. 2001;10:1317–1325. - PubMed
    1. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci. 1994;91:3228–3232. - PMC - PubMed

Publication types

MeSH terms